Free Cash Flow

Satsuma Pharmaceuticals, Inc. (STSA)

$0.9103

+0.08 (+9.56%)

Free Cash Flow

Year
A/P
Revenue
Revenue (%)
Operating Cash Flow
Operating Cash Flow (%)
Capital Expenditure
Capital Expenditure (%)
Free Cash Flow

FCF Unlevered from cash flow statement